Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Bodyw Mov Ther ; 26: 530-537, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33992293

RESUMEN

INTRODUCTION: Determining the normal values for acoustic radiation force impulse (ARFI) shear wave elastography of the thoracolumbar fascia (TLF) and define possible factors of influence. METHODS: We measured the shear wave velocity (SWV) in m/s and the diameter (anterior-posterior) in mm of the TLF bilateral in 267 healthy participants with the Acuson S3000™ (Siemens) using the virtual touch image quantification mode (VTIQ). The parameters were tested for correlations with the anthropometric data of the participants, between different age groups and the genders, as well as information obtained from the history, such as smoking and sporting activities. RESULTS: We determined a mean SWV of 3.28 ±â€¯0.55 m/s for the left thoracolumbar fascia and 3.44 ±â€¯0.55 m/s for the right. The diameter on the right was 2.7 ±â€¯0.8 mm. On the left, it was 2.7 ±â€¯0.9 mm. Neither body mass index (BMI) nor gender had a significant effect on either of the measured parameters (p > 0.05). The same goes for regular medication, sporting activity or the consumption of alcohol (p > 0.05). The results concerning the effect of smoking and age were inconclusive as they only had a significant influence to either the right or the left side of the TLF but not on the other side. CONCLUSIONS: We collected the normal value for ARFI shear wave elastography of the TLF in 267 healthy participants. Furthermore, neither gender, BMI, sports activity nor the consumption of alcohol affected the elasticity or the diameter of the thoracolumbar fascia.


Asunto(s)
Diagnóstico por Imagen de Elasticidad , Acústica , Elasticidad , Fascia/diagnóstico por imagen , Femenino , Humanos , Masculino , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Fumar
2.
J Bodyw Mov Ther ; 22(1): 105-111, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29332731

RESUMEN

OBJECTIVE: The aim of the study was to examine the quantitative tissue properties of the Achilles tendon and plantar fascia using a handheld, non-invasive MyotonPRO device, in order to generate normal values and examine the biomechanical relationship of both structures. DESIGN: Prospective study of a large, healthy sample population. PARTICIPANTS: The study sample included 207 healthy subjects (87 males and 120 females) for the Achilles tendon and 176 healthy subjects (73 males and 103 females) for the plantar fascia. For the correlations of the tissue parameters of the Achilles tendon and plantar fascia an intersection of both groups was formed which included 150 healthy subjects (65 males and 85 females). INTERVENTIONS: All participants were measured in a prone position. Consecutive measurements of the Achilles tendon and plantar fascia were performed by MyotonPRO device at defined sites. RESULTS: For the left and right Achilles tendons and plantar fasciae all five MyotonPRO parameters (Frequency [Hz], Decrement, Stiffness [N/m], Creep and Relaxation Time [ms]) were calculated of healthy males and females. The correlation of the tissue parameters of the Achilles tendon and plantar fascia showed a significant positive correlation of all parameters on the left as well as on the right side. CONCLUSIONS: The MyotonPRO is a feasible device for easy measurement of passive tissue properties of the Achilles tendon and plantar fascia in a clinical setting. The generated normal values of the Achilles tendon and plantar fascia are important for detecting abnormalities in patients with Achilles tendinopathy or plantar fasciitis in the future. Biomechanically, both structures are positively correlated. This may provide new aspects in the diagnostics and therapy of plantar fasciitis and Achilles tendinopathy.


Asunto(s)
Tendón Calcáneo/fisiología , Fascia/fisiología , Pie/fisiología , Manometría/instrumentación , Femenino , Humanos , Masculino , Músculo Esquelético/fisiología , Estudios Prospectivos , Soporte de Peso
3.
BMC Res Notes ; 8: 640, 2015 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-26530296

RESUMEN

BACKGROUND: Objective of the present cross-sectional study was to investigate the impact of caffeine consumption on fatty liver and serum alanine aminotransferase (ALT) concentrations in a random population sample. METHODS: All subjects (n = 1452; 789 women, 663 men; average age 42.3 ± 12.8 years) underwent ultrasonographic examination of the liver and completed a standardized questionnaire regarding personal and lifestyle data, in particular relating to coffee consumption and past medical history. In addition, anthropometric data were documented and laboratory examinations performed. Statistical interpretation of the data was performed descriptively and by means of bivariate and multivariate analysis. RESULTS: Data of the present study demonstrated a significant association between hepatic steatosis male gender (p < 0.0001), advanced age (p < 0.0001) and elevated body-mass index (BMI; p < 0.0001). No association between caffeine consumption and fatty liver was identified. An association between caffeine consumption and elevated serum ALT concentrations was not identified. CONCLUSIONS: The findings of the present study provide no evidence for an association between caffeine consumption and either the prevalence of hepatic steatosis or serum ALT concentrations.


Asunto(s)
Café , Investigación Participativa Basada en la Comunidad/métodos , Hígado/patología , Enfermedad del Hígado Graso no Alcohólico/diagnóstico , Adolescente , Adulto , Anciano , Alanina Transaminasa/sangre , Índice de Masa Corporal , Cafeína/administración & dosificación , Estimulantes del Sistema Nervioso Central/administración & dosificación , Estudios Transversales , Femenino , Humanos , Hígado/diagnóstico por imagen , Hígado/efectos de los fármacos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios , Ultrasonografía , Adulto Joven
4.
BMC Gastroenterol ; 9: 74, 2009 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-19814821

RESUMEN

BACKGROUND: Animal experiments have shown a protective effect of vitamin C on the formation of gallstones. Few data in humans suggest an association between reduced vitamin C intake and increased prevalence of gallstone disease. The aim of this study was to assess the possible association of regular vitamin C supplementation with gallstone prevalence. METHODS: An observational, population-based study of 2129 subjects aged 18-65 years randomly selected from the general population in southern Germany was conducted. Abdominal ultrasound examination, completion of a standardized questionnaire, compilation of anthropometric data and blood tests were used. Data were collected in November and December 2002. Data analysis was conducted between December 2005 and January 2006. RESULTS: Prevalence of gallstones in the study population was 7.8% (167/2129). Subjects reporting vitamin C supplementation showed a prevalence of 4.7% (11/232), whereas in subjects not reporting regular vitamin C supplementation, the prevalence was 8.2% (156/1897). Female gender, hereditary predisposition, increasing age and body-mass index (BMI) were associated with increased prevalence of gallstones. Logistic regression with backward elimination adjusted for these factors showed reduced gallstone prevalence for vitamin C supplementation (odds ratio, OR 0.34; 95% confidence interval, CI 0.14 to 0.81; P = 0.01), increased physical activity (OR 0.62; 95% CI, 0.42 to 0.94; P = 0.02), and higher total cholesterol (OR 0.65; 95% CI, 0.52 to 0.79; P < 0.001). CONCLUSION: Regular vitamin C supplementation and, to a lesser extent, increased physical activity and total cholesterol levels are associated with a reduced prevalence of gallstones. Regular vitamin C supplementation might exert a protective effect on the development of gallstones.


Asunto(s)
Ácido Ascórbico/uso terapéutico , Suplementos Dietéticos , Cálculos Biliares/epidemiología , Cálculos Biliares/prevención & control , Adolescente , Adulto , Factores de Edad , Anciano , Índice de Masa Corporal , Niño , Femenino , Cálculos Biliares/fisiopatología , Alemania/epidemiología , Encuestas Epidemiológicas , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Actividad Motora/fisiología , Prevalencia , Estudios Retrospectivos , Factores Sexuales , Adulto Joven
5.
Eur J Gastroenterol Hepatol ; 15(11): 1165-70, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14560148

RESUMEN

BACKGROUND AND AIMS: Osteoporosis may occur in 25-30% of patients with Crohn's disease. Its pathogenesis is not completely understood. Both systemic inflammation in acute disease and treatment with systemic glucocorticoids have been implicated. The aim of the present study was to investigate changes in bone density and biochemical markers of bone metabolism before and during a 3-month period of high-dose glucocorticoid treatment for acute flare-up of Crohn's disease. METHODS: Twenty-five patients with active Crohn's disease requiring systemic glucocorticoid treatment (prednisolone, 60 mg/day) were investigated. Lumbar spine and femoral neck bone mineral densitometry was performed at baseline and again after 3 months. Clinical examinations including evaluation of the Crohn's disease activity index and measurement of the biochemical markers osteocalcin, deoxypyridinoline, osteoprotegerin and the soluble receptor activator of NF-kappaB ligand were performed prior to, and at 1, 2 and 12 weeks following steroid administration. RESULTS Median lumbar bone mineral density decreased significantly during the observation period by 1.04% from -0.84 (t score; range, -2.8 to +0.57) to -0.95 (range, -3.1 to +0.40; P = 0.022), while bone density of the total femur decreased by 2.9% from -0.83 (range, -2.61 to +1.86) to -0.90 (range, -2.65 to +0.19; P = 0.01). Serum levels of osteocalcin, a bone formation marker, and osteoprotegerin, an anti-resorptive cytokine produced by osteoblasts, decreased after the first 2 weeks of treatment and reached baseline levels after 3 months. No significant change was found for the bone resorption marker deoxypyridinoline, while soluble receptor activator of NF-kappaB ligand, a cytokine promoting bone resorption, tended to increase during steroid treatment. CONCLUSION: A decrease in bone mineral density in patients with Crohn's disease appears to result, at least in part, from a short-term effect of systemic glucocorticoid. Modulation of osteoclastogenesis by the receptor activator of NF-kappaB ligand/osteoprotegerin cytokine system and decreased osteoblastic function may be the underlying molecular basis.


Asunto(s)
Huesos/efectos de los fármacos , Enfermedad de Crohn/tratamiento farmacológico , Glucocorticoides/administración & dosificación , Glicoproteínas/metabolismo , Prednisolona/administración & dosificación , Receptores Citoplasmáticos y Nucleares/metabolismo , Enfermedad Aguda , Adulto , Fosfatasa Alcalina/sangre , Fosfatasa Alcalina/orina , Biomarcadores/sangre , Biomarcadores/orina , Densidad Ósea/efectos de los fármacos , Huesos/metabolismo , Enfermedad de Crohn/metabolismo , Enfermedad de Crohn/fisiopatología , Esquema de Medicación , Femenino , Glucocorticoides/uso terapéutico , Humanos , Masculino , Osteocalcina/sangre , Osteocalcina/orina , Osteoprotegerina , Proyectos Piloto , Prednisolona/uso terapéutico , Estudios Prospectivos , Receptores del Factor de Necrosis Tumoral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA